These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 34446022)

  • 21. A new oligonucleotide array for the detection of multidrug and extensively drug-resistance tuberculosis.
    Chen CY; Weng JY; Huang HH; Yen WC; Tsai YH; Cheng TC; Jou R
    Sci Rep; 2019 Mar; 9(1):4425. PubMed ID: 30872613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Second-line Drug Resistance Characterization in
    Sethi S; Agarwal P; Khaneja R; Kumar N; Kumar N; Chandna J; Aggarwal AN; Yadav R
    J Epidemiol Glob Health; 2020 Mar; 10(1):42-45. PubMed ID: 32175709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the MolecuTech
    Cho EJ; Kang MR; Kim JH; Lee JI; Son ES; Park CH; Aung WW; Lee JS
    Int J Tuberc Lung Dis; 2022 Sep; 26(9):869-874. PubMed ID: 35996285
    [No Abstract]   [Full Text] [Related]  

  • 24. High degree of fluoroquinolone resistance among extrapulmonary tuberculosis patients at a tertiary care center in North India.
    Chaubey J; Shrivastava D; Pawar S; Singh BK; Sharma R; Sinha S
    Int J Mycobacteriol; 2020; 9(3):309-312. PubMed ID: 32862166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genotype MTBDRsl line probe assay shortens time to diagnosis of extensively drug-resistant tuberculosis in a high-throughput diagnostic laboratory.
    Barnard M; Warren R; Gey Van Pittius N; van Helden P; Bosman M; Streicher E; Coetzee G; O'Brien R
    Am J Respir Crit Care Med; 2012 Dec; 186(12):1298-305. PubMed ID: 23087027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Baseline resistance and cross-resistance among fluoroquinolones in multidrug-resistant Mycobacterium tuberculosis isolates at a national reference laboratory in India.
    Mamatha HG; Shanthi V
    J Glob Antimicrob Resist; 2018 Mar; 12():5-10. PubMed ID: 28887289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa.
    Maningi NE; Malinga LA; Antiabong JF; Lekalakala RM; Mbelle NM
    BMC Infect Dis; 2017 Dec; 17(1):795. PubMed ID: 29282012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The diagnostic accuracy of the MTBDRplus and MTBDRsl assays for drug-resistant TB detection when performed on sputum and culture isolates.
    Tomasicchio M; Theron G; Pietersen E; Streicher E; Stanley-Josephs D; van Helden P; Warren R; Dheda K
    Sci Rep; 2016 Feb; 6():17850. PubMed ID: 26860462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiological profile of multidrug-resistant and extensively drug-resistant Mycobacterium Tubrculosis among Congolese patients.
    Elion Assiana DO; Abdul JBPA; Linguissi LSG; Epola M; Vouvoungui JC; Mabiala A; Biyogho CM; Ronald Edoa J; Adegbite BR; Adegnika AA; Elton L; Canseco JO; McHugh TD; Ahombo G; Ntoumi F
    Ann Clin Microbiol Antimicrob; 2021 Dec; 20(1):84. PubMed ID: 34920727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance of an Xpert-based diagnostic algorithm for the rapid detection of drug-resistant tuberculosis among high-risk populations in a low-incidence setting.
    Chiang TY; Fan SY; Jou R
    PLoS One; 2018; 13(7):e0200755. PubMed ID: 30011319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of GenoType MTBDR
    Ejo M; Van Deun A; Nunn A; Meredith S; Ahmed S; Dalai D; Tumenbayar O; Tsogt B; Dat PT; Ha DTM; Hang PT; Kokebu D; Teferi M; Mebrahtu T; Ngubane N; Moodliar R; Duckworth L; Conradie F; Enduwamahoro E; Keysers J; De Rijk P; Mulders W; Diro E; Rigouts L; de Jong BC; Torrea G
    Int J Tuberc Lung Dis; 2021 Oct; 25(10):839-845. PubMed ID: 34615581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Underestimation of the resistance of Mycobacterium tuberculosis to second-line drugs by the new GenoType MTBDRsl test.
    Jin J; Shen Y; Fan X; Diao N; Wang F; Wang S; Weng X; Zhang W
    J Mol Diagn; 2013 Jan; 15(1):44-50. PubMed ID: 23159109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of the REBA MTB-Rifa® assay for rapid detection of rifampicin resistant Mycobacterium tuberculosis.
    Cho E; Shamputa IC; Kwak HK; Lee J; Lee M; Hwang S; Jeon D; Kim CT; Cho S; Via LE; Barry CE; Lee JS
    BMC Infect Dis; 2013 Oct; 13():478. PubMed ID: 24128118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low resistance to first and second line anti-tuberculosis drugs among treatment naive pulmonary tuberculosis patients in southwestern Uganda.
    Orikiriza P; Tibenderana B; Siedner MJ; Mueller Y; Byarugaba F; Moore CC; Evans EE; Bonnet M; Page AL; Bazira J; Boum Y
    PLoS One; 2015; 10(2):e0118191. PubMed ID: 25658921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for extensive drug resistance in multidrug-resistant tuberculosis cases: a case-case study.
    Guglielmetti L; Veziris N; Aubry A; Brossier F; Bernard C; Sougakoff W; Jarlier V; Robert J
    Int J Tuberc Lung Dis; 2018 Jan; 22(1):54-59. PubMed ID: 29297426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance of the MTBDRsl Line probe assay for rapid detection of resistance to second-line anti-tuberculosis drugs and ethambutol in China.
    Zeng X; Jing W; Zhang Y; Duan H; Huang H; Chu N
    Diagn Microbiol Infect Dis; 2017 Oct; 89(2):112-117. PubMed ID: 27345127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns and profiles of drug resistance-conferring mutations in
    Reta MA; Maningi NE; Fourie PB
    Front Public Health; 2024; 12():1356826. PubMed ID: 38566794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of genotype MTBDRsl assay to detect drug resistance associated with fluoroquinolones, aminoglycosides and ethambutol on clinical sediments.
    Ajbani K; Nikam C; Kazi M; Gray C; Boehme C; Balan K; Shetty A; Rodrigues C
    PLoS One; 2012; 7(11):e49433. PubMed ID: 23166667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increasing prevalence of resistance to second-line drugs among multidrug-resistant Mycobacterium tuberculosis isolates in Kuwait.
    Al-Mutairi NM; Ahmad S; Mokaddas E
    Sci Rep; 2021 Apr; 11(1):7765. PubMed ID: 33833390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The burden of pre-extensively and extensively drug-resistant tuberculosis among MDR-TB patients in the Amhara region, Ethiopia.
    Shibabaw A; Gelaw B; Gebreyes W; Robinson R; Wang SH; Tessema B
    PLoS One; 2020; 15(2):e0229040. PubMed ID: 32053661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.